This result is reminiscent of the higher APOBEC3-associated mutation burdens observed in breast cancers that develop in carriers of a common germline deletion polymorphism that effectively deletes APOBEC3B and stabilizes the expression of the resulting APOBEC3A–APOBEC3B hybrid transcript21,45. This evidence concerns the gene APOBEC3A and breast carcinoma.